Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 3Gynecologic 3

Conditions

Obesity 219Neoplasms 82Mucositis 66Sexual Dysfunction, Physiological 65Breast Neoplasms 64Polycystic Ovary Syndrome 56Overweight 55Dyspnea 32Motor Activity 30Constipation 30Head and Neck Neoplasms 28Prostatic Neoplasms 25Weight Loss 24Multiple Endocrine Neoplasia Type 1 19Colorectal Neoplasms 18Pain 16Diabetes Mellitus 16Stomatitis 15Lung Neoplasms 15Opioid-Induced Constipation 14Depression 14Cardiovascular Diseases 14Insulin Resistance 13Endometrial Neoplasms 13Sexuality 11Sexual Dysfunctions, Psychological 11Diabetes Mellitus, Type 2 11Fatigue 10Anxiety Disorders 10Stomach Neoplasms 8

Interventions

licogliflozin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Hyperandrogenism × Other × Clear all
NCT03902301 2022-04-26

ProjectPCOS

Poznan University of Life Sciences

Phase NA Completed
80 enrolled
Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT03152591 2021-01-05

PCOS

Novartis

Phase 2 Completed
29 enrolled 24 charts
Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

NCT01313455 2019-05-31

Adrenal Hyperplasia Among Young People With PCOS

National Institutes of Health Clinical Center (CC)

Completed
96 enrolled
Other

Adrenal Hyperplasia, Congenital, Obesity, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡